Zhang Lin, An Xiaofei, Wang Qiuyu, He Ming
Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200025, China.
Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
Lung. 2016 Aug;194(4):595-603. doi: 10.1007/s00408-016-9901-4. Epub 2016 May 28.
Airway smooth muscle cell (ASMC) phenotypic modulation is one of the key factors contributing to asthma. Temperature changes may induce asthma, and these changes are known to be related to the temperature-sensitive transient receptor potential channels (TS-TRPs). The present study was designed to investigate the cellular functions of cold-sensitive channels, TRPM8 and TRPA1, in the phenotypic modulation of ASMCs.
A rat asthma model was constructed and the expression of TS-TRPs in ASM was tested. Using the agonists and antagonists for both TRPM8 and TRPA1, the effects of cold-sensitive channels on the phenotypic modulation of ASMCs were evaluated by measurement of contractile protein expression and cell proliferation and migration. Signaling pathways and matrix metalloproteinase-2 (MMP-2) activity were assayed with Western blotting and gelatin zymography.
TRPM8 and TRPA1 were decreased in the ASM of the rat asthma model. Icilin and menthol, agonists for TRPM8 and TRPA1, inhibited ASMC proliferation and migration induced by fetal bovine serum (FBS) or platelet-derived growth factor (PDGF). Moreover, icilin reversed the FBS-induced inhibition of the expression of contractile phenotype markers, smooth muscle α-actin, and SM22α. Icilin also antagonized the activation of p38 and MMP-2 and the repression of p21 caused by FBS.
Our findings show, for the first time, that the activation of TRPM8 and TRPA1 inhibits ASMC proliferative phenotype. These data suggest that TRPM8 and TRPA1 agonists may be promising new therapies for asthma.
气道平滑肌细胞(ASMC)表型调节是导致哮喘的关键因素之一。温度变化可能诱发哮喘,且已知这些变化与温度敏感型瞬时受体电位通道(TS-TRPs)有关。本研究旨在探讨冷敏通道TRPM8和TRPA1在ASMC表型调节中的细胞功能。
构建大鼠哮喘模型,检测ASM中TS-TRPs的表达。使用TRPM8和TRPA1的激动剂和拮抗剂,通过测量收缩蛋白表达、细胞增殖和迁移来评估冷敏通道对ASMC表型调节的影响。用蛋白质免疫印迹法和明胶酶谱法检测信号通路和基质金属蛋白酶-2(MMP-2)活性。
大鼠哮喘模型的ASM中TRPM8和TRPA1减少。TRPM8和TRPA1的激动剂艾考糊精和薄荷醇抑制了胎牛血清(FBS)或血小板衍生生长因子(PDGF)诱导的ASMC增殖和迁移。此外,艾考糊精逆转了FBS诱导的收缩表型标志物平滑肌α-肌动蛋白和SM22α表达的抑制。艾考糊精还拮抗了FBS引起的p38和MMP-2的激活以及p21的抑制。
我们的研究结果首次表明,TRPM8和TRPA1的激活抑制了ASMC的增殖表型。这些数据表明,TRPM8和TRPA1激动剂可能是有前景的哮喘新疗法。